BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11518722)

  • 1. The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.
    Duncan G; McCormick C; Tufaro F
    J Clin Invest; 2001 Aug; 108(4):511-6. PubMed ID: 11518722
    [No Abstract]   [Full Text] [Related]  

  • 2. New perspectives on the molecular basis of hereditary bone tumours.
    McCormick C; Duncan G; Tufaro F
    Mol Med Today; 1999 Nov; 5(11):481-6. PubMed ID: 10529789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
    Stickens D; Brown D; Evans GA
    Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
    McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
    Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.
    Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT
    Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neoplastic pathogenesis of solitary and multiple osteochondromas.
    Porter DE; Simpson AH
    J Pathol; 1999 Jun; 188(2):119-25. PubMed ID: 10398153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.
    Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT
    J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple hereditary exostosis, EXT genes, and skeletal development.
    Sandell LJ
    J Bone Joint Surg Am; 2009 Jul; 91 Suppl 4():58-62. PubMed ID: 19571069
    [No Abstract]   [Full Text] [Related]  

  • 9. Hereditary multiple exostoses and heparan sulfate polymerization.
    Zak BM; Crawford BE; Esko JD
    Biochim Biophys Acta; 2002 Dec; 1573(3):346-55. PubMed ID: 12417417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparan sulfate, an essential of CNS development].
    Inatani M; Yamaguchi Y
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(15 Suppl):2369-75. PubMed ID: 15552988
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent progress on the study of calcium-metabolism regulating factors--parathyroid hormone-related protein and its function].
    Ootsuru A; Yamashita S
    Nihon Naika Gakkai Zasshi; 1999 Jul; 88(7):1271-6. PubMed ID: 10465976
    [No Abstract]   [Full Text] [Related]  

  • 12. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes.
    Stickens D; Clines G; Burbee D; Ramos P; Thomas S; Hogue D; Hecht JT; Lovett M; Evans GA
    Nat Genet; 1996 Sep; 14(1):25-32. PubMed ID: 8782816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The exostosin family: proteins with many functions.
    Busse-Wicher M; Wicher KB; Kusche-Gullberg M
    Matrix Biol; 2014 Apr; 35():25-33. PubMed ID: 24128412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
    Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
    Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biosynthesis of heparan sulfate and the tumor suppressor EXT gene family].
    Kitagawa H; Sugahara K
    Tanpakushitsu Kakusan Koso; 2000 Mar; 45(4):579-86. PubMed ID: 10714174
    [No Abstract]   [Full Text] [Related]  

  • 16. EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis.
    Bovée JV; Hameetman L; Kroon HM; Aigner T; Hogendoorn PC
    J Pathol; 2006 Jul; 209(3):411-9. PubMed ID: 16622899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple exostoses].
    Toguchida J; Nagayama S
    Nihon Rinsho; 2000 Jul; 58(7):1473-8. PubMed ID: 10921326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis.
    Senay C; Lind T; Muguruma K; Tone Y; Kitagawa H; Sugahara K; Lidholt K; Lindahl U; Kusche-Gullberg M
    EMBO Rep; 2000 Sep; 1(3):282-6. PubMed ID: 11256613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
    Stickens D; Zak BM; Rougier N; Esko JD; Werb Z
    Development; 2005 Nov; 132(22):5055-68. PubMed ID: 16236767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of the glucuronosyltransferase domain in the heparan sulfate copolymerase EXT1 by analysis of Chinese hamster ovary cell mutants.
    Wei G; Bai X; Gabb MM; Bame KJ; Koshy TI; Spear PG; Esko JD
    J Biol Chem; 2000 Sep; 275(36):27733-40. PubMed ID: 10864928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.